FeesSafety
Pluang+

ADARx CEO to speak at UBS Global Biopharma Conference on Nov 16 with live webcast.

Market News
09 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Neutral
ADARx CEO to speak at UBS Global Biopharma Conference on Nov 16 with live webcast.

ADARx Pharmaceuticals announced that CEO Zhen Li will participate in a fireside chat at the UBS Global Biopharma Conference in London on November 16. The event will be webcast live and archived for 90 days on ADARx's investor website. ADARx is a late-stage biotech company developing next-generation siRNA therapeutics targeting various diseases, with multiple clinical and preclinical programs. This presentation highlights ADARx's ongoing efforts to advance RNA-based treatments for unmet medical needs.

ADARx Pharmaceuticals' upcoming presentation at the UBS Global Biopharma Conference is provided here with Pluang's Health sector market context. For readers following Health stocks, as of Nov 09, 2026 19:41 WIB, 121 of 150 priced US Health-sector stocks rose while 18 fell. Among notable movers, Immunovant Inc. (IMVT) gained 9.73% to USD 33.50 with a typical hold time of 17 days, contrasting with Abeona Therapeutics Inc. (ABEO) which dropped 12.47% to USD 3.65 and Inovio Pharmaceuticals Inc. (INO) which rose 8.64% to USD 1.32 with a longer typical hold time of 41 days.

More News

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
1 hour ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
1 hour ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
1 hour ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
Credit Agricole Toulouse 31 reports weekly cooperative investment certificate buybacks from Nov 2-6, 2026.

Credit Agricole Toulouse 31 reports weekly cooperative investment certificate buybacks from Nov 2-6, 2026.

Credit Agricole Toulouse 31 disclosed its weekly transactions involving the buyback of its cooperative investment certificates (CCI) from November 2 to November 6, 2026. The bank repurchased varying volumes daily, with prices ranging around 98.82 to ...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App